Bernard J. Gersh
Mayo Clinic
Internal medicineSurgeryCardiologyIntensive care medicineHazard ratioHeart failureCoronary artery diseaseAtrial fibrillationRevascularizationHeart diseaseHypertrophic cardiomyopathyAngioplastyPercutaneous coronary interventionPopulationIn patientConventional PCIMyocardial infarctionStrokeMedicineEjection fraction
Publications 1161
#1Konstantinos C. Siontis (Mayo Clinic)H-Index: 23
#2Peter A. Noseworthy (Mayo Clinic)H-Index: 45
Last. Bernard J. Gersh (Mayo Clinic)H-Index: 163
view all 0 authors...
#1Alan SugrueH-Index: 12
Last. Malini MadhavanH-Index: 21
view all 7 authors...
#1William E. Boden (BU: Boston University)H-Index: 44
#2Bernard J. Gersh (Mayo Clinic)H-Index: 163
#1Saraschandra Vallabhajosyula (Emory University)H-Index: 23
#2Sri Harsha Patlolla (Mayo Clinic)H-Index: 7
Last. Bernard J. Gersh (Mayo Clinic)H-Index: 163
view all 6 authors...
There are limited contemporary data on the management and outcomes of acute myocardial infarction (AMI) in patients with concomitant acute respiratory infections. Hence, using the National Inpatient Sample from 2000-2017, adult AMI admissions with and without concomitant respiratory infections were identified. We evaluated in-hospital mortality, utilization of cardiac procedures, hospital length of stay, hospitalization costs, and discharge disposition. Among 10,880,856 AMI admissions, respirato...
#2Rolf WachterH-Index: 51
Last. James A. ReiffelH-Index: 49
view all 10 authors...
#1Vinayak Kumar (Mayo Clinic)H-Index: 3
#2Armando Manduca (Mayo Clinic)H-Index: 59
Last. Nandan S. Anavekar (Mayo Clinic)H-Index: 25
view all 14 authors...
BACKGROUND Myocardial volume is assumed to be constant over the cardiac cycle in the echocardiographic models used by professional guidelines, despite evidence that suggests otherwise. The aim of this paper is to use literature-derived myocardial strain values from healthy patients to determine if myocardial volume changes during the cardiac cycle. METHODS A systematic review for studies with longitudinal, radial, and circumferential strain from echocardiography in healthy volunteers ultimately ...
#1Anita Nguyen (Mayo Clinic)H-Index: 10
#2Hartzell V. Schaff (Mayo Clinic)H-Index: 131
Last. Rick A. Nishimura (Mayo Clinic)H-Index: 128
view all 8 authors...
BACKGROUND Surgical myectomy eliminates symptoms in most patients with obstructive hypertrophic cardiomyopathy, but dyspnea and/or angina can recur in some. This study investigated clinical features associated with a lack of clinical improvement postoperatively. METHODS Between March 2007 and December 2012, 963 patients underwent transaortic septal myectomy at our clinic. Six hundred one patients received standardized follow-up questionnaires, which were answered by 409 (68.1%). We compared clin...
1 CitationsSource
#1Daokun Sun (Mayo Clinic)H-Index: 1
#2Hartzell V. Schaff (Mayo Clinic)H-Index: 131
Last. Barry A. Borlaug (Mayo Clinic)H-Index: 76
view all 4 authors...
Transapical septal myectomy can be performed for patients with nonobstructive hypertrophic cardiomyopathy and diastolic dysfunction to enlarge the LV cavity. The procedure may also include limited shaving of severely hypertrophied papillary muscles. This report illustrates the usefulness of papillary muscle resection to enlarge the left ventricle in a patient with nonobstructive hypertrophic cardiomyopathy and preexisting mitral valve prosthesis.
#1Thomas A. Kite (University Hospitals of Leicester NHS Trust)H-Index: 1
#2Peter Ludman (University of Birmingham)H-Index: 41
Last. Anthony H. Gershlick (University Hospitals of Leicester NHS Trust)H-Index: 59
view all 39 authors...
Abstract Background Published data suggest worse outcomes in acute coronary syndrome (ACS) patients and concurrent coronavirus disease 2019 (COVID-19) infection. Mechanisms remain unclear. Objectives The purpose of this study was to report the demographics, angiographic findings, and in-hospital outcomes of COVID-19 ACS patients and compare these with pre–COVID-19 cohorts. Methods From March 1, 2020 to July 31, 2020, data from 55 international centers were entered into a prospective, COVID-ACS R...
2 CitationsSource
#1Xiaoxi Yao (Mayo Clinic)H-Index: 23
#2Zachi I. Attia (Mayo Clinic)H-Index: 12
Last. Peter A. Noseworthy (Mayo Clinic)H-Index: 45
view all 12 authors...
Background Clinical trials are a fundamental tool to evaluate medical interventions but are time-consuming and resource-intensive. Objectives To build infrastructure for digital trials to improve efficiency and generalizability and test it using a study to validate an artificial intelligence (AI) algorithm to detect atrial fibrillation (AF). Design We will prospectively enroll 1,000 patients who underwent an ECG for any clinical reason in routine practice, do not have a previous diagnosis of AF ...